UBS Group
BUDX

UBS Group’s Cannabis Growth ETF BUDX Stock Holding History

UBS Group’s Portfolio BUDX Stock Details BUDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-956
Closed -$11K – 11722
2022
Q1 		$11K Buy
956
+237
+33% +$2.77K ﹤0.01% 8378
2021
Q4 		$10K Buy
+719
New +$12.2K ﹤0.01% 8867

UBS Group's BUDX Position: Q2 2022 in Review

UBS Group sold out of Cannabis Growth ETF (BUDX) in Q2 2022, closing a stake of 956 shares — an estimated $11K sold.

UBS Group first reported a position in BUDX in Q4 2021 and held it in 2 quarters. The position peaked at $11K in Q1 2022. 0 funds tracked by Wall St. Rank hold BUDX as of Q2 2022.

  • UBS Group reported no remaining Cannabis Growth ETF position as of Q2 2022 after selling out during the quarter.
  • UBS Group sold 956 Cannabis Growth ETF shares in Q2 2022, an estimated $11K.
  • UBS Group first reported a position in Cannabis Growth ETF in Q4 2021 and held it in 2 quarters.
  • UBS Group's Cannabis Growth ETF position peaked at $11K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Cannabis Growth ETF as of Q2 2022.

Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.